These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9781975)

  • 1. Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease.
    Lu C; Dabrowski P; Fragasso G; Chierchia SL
    Am J Cardiol; 1998 Oct; 82(7):898-901. PubMed ID: 9781975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dobutamine stress echocardiography and the effects of trimetazidine on left ventricular dysfunction in patients with coronary artery disease.
    Chierchia SL
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S19-21. PubMed ID: 11286302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimetazidine improves myocardial perfusion and left ventricular function in ischemic left ventricular dysfunction.
    Feola M; Biggi A; Francini A; Leonardi G; Ribichini F; Ferrero V; Uslenghi E
    Clin Nucl Med; 2004 Feb; 29(2):117-8. PubMed ID: 14734913
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G; Gebara O; Vitale C; Caminiti G; Wajngarten M; Volterrani M; Ramires JA; Rosano G; Fini M
    Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy.
    Belardinelli R; Purcaro A
    Eur Heart J; 2001 Dec; 22(23):2164-70. PubMed ID: 11913478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
    Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G
    Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo or trimetazidine (99m)Tc tetrofosmin myocardial SPECT and low-dose dobutamine echocardiography in hibernating myocardium.
    Feola M; Biggi A; Francini A; Leonardi G; Vado A; Ribichini F; Uslenghi E
    Arch Med Res; 2006 Jan; 37(1):117-22. PubMed ID: 16314196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimetazidine to reverse ischemia in patients with class I or II angina: a randomized, double-blind, placebo-controlled dobutamine-atropine stress echocardiography study.
    Cesar LA; Mathias W; Armaganijan D; Gimenez V; Jallad S; Del Monaco MI; Bicudo L; Meneguin S; Gomes EP; Brasil CK; Ramires JF
    Coron Artery Dis; 2007 Jun; 18(4):259-63. PubMed ID: 17496489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C; Wajngaten M; Sposato B; Gebara O; Rossini P; Fini M; Volterrani M; Rosano GM
    Eur Heart J; 2004 Oct; 25(20):1814-21. PubMed ID: 15474696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
    Multicentral Collaborative Group on Trimetazidine (Phase IV)
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):793-5. PubMed ID: 16266453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G; Perseghin G; De Cobelli F; Esposito A; Palloshi A; Lattuada G; Scifo P; Calori G; Del Maschio A; Margonato A
    Eur Heart J; 2006 Apr; 27(8):942-8. PubMed ID: 16510466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of trimetazidine on heart rate variability and left ventricular systolic performance in patients with coronary artery disease after percutaneous transluminal angioplasty.
    Birand A; Kudaiberdieva GZ; Batyraliev TA; Akgul F; Usal A
    Angiology; 1997 May; 48(5):413-22. PubMed ID: 9158385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimetazidine on ischemic injury and reperfusion in coronary artery bypass grafting.
    Martins GF; Siqueira Filho AG; Santos JB; Assunção CR; Bottino F; Carvalho KG; Valência A
    Arq Bras Cardiol; 2011 Sep; 97(3):209-16. PubMed ID: 21808851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical benefits of a metabolic approach in the management of coronary patients.
    Marzilli M
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V25-30. PubMed ID: 11206100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
    Shlyakhto EV; Almazov VV; Nifontov EM; Vakhrameyeva IV; Rudomanov OG; Zakharov DV; Kazarin VV; Vakhrameyeva NV
    Am J Cardiovasc Drugs; 2002; 2(2):119-24. PubMed ID: 14727987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of acetyl-CoA C-acyltransferase inhibitor trimetazidine on parameters of global and local systolic and diastolic functions of left ventricular myocardium in patients with combined postinfarction ischemic syndrome].
    Kastanaian AA; Nelasov NIu; Eroshenko OL; Kazarian NB; Drobotia NV
    Kardiologiia; 2003; 43(9):21-7. PubMed ID: 14593366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.
    Leonardo F; Fragasso G; Rossetti E; Dabrowski P; Pagnotta P; Rosano GM; Chierchia SL
    Cardiologia; 1999 Dec; 44(12):1065-9. PubMed ID: 10687257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.